| 000 | 01709 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513141720.0 | ||
| 264 | 0 | _c19980609 | |
| 008 | 199806s 0 0 eng d | ||
| 022 | _a0393-2990 | ||
| 024 | 7 |
_a10.1023/a:1007404620701 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFahrer, H | |
| 245 | 0 | 0 |
_aLongterm survey (7 years) in a population at risk for Lyme borreliosis: what happens to the seropositive individuals? _h[electronic resource] |
| 260 |
_bEuropean journal of epidemiology _cFeb 1998 |
||
| 300 |
_a117-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcrodermatitis _xepidemiology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Bacterial _xblood |
| 650 | 0 | 4 |
_aArthritis, Infectious _xepidemiology |
| 650 | 0 | 4 |
_aBorrelia burgdorferi Group _ximmunology |
| 650 | 0 | 4 |
_aErythema Chronicum Migrans _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xblood |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 |
_aLyme Disease _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeroepidemiologic Studies |
| 650 | 0 | 4 | _aSports |
| 650 | 0 | 4 |
_aSwitzerland _xepidemiology |
| 700 | 1 | _aSauvain, M J | |
| 700 | 1 | _aZhioua, E | |
| 700 | 1 | _aVan Hoecke, C | |
| 700 | 1 | _aGern, L E | |
| 773 | 0 |
_tEuropean journal of epidemiology _gvol. 14 _gno. 2 _gp. 117-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1007404620701 _zAvailable from publisher's website |
| 999 |
_c9523354 _d9523354 |
||